AOA Dx is developing the next frontier in early-stage cancer detection for women through its pioneering work in glycolipids and proprietary biomarker technology. Our revolutionary tumor marker ganglioside platform, GlycoLocate™, is paving the way for life-saving early cancer detection. In a first of its kind, AOA Dx is developing AKRIVIS GD™, an early-stage liquid biopsy test for ovarian cancer, that has proven excellent sensitivity and specificity in a recent study. We foresee novel tumor biomarker gangliosides as the future for diagnosis, prognosis, monitoring, and eventually targeted therapies across multiple cancers. AOA Dx was co-founded by three experts and passionate advocates of women’s health, who have worked together at two previous diagnostic startups, that both resulted in successful exits upon commercialization. 
 
AOA Dx, a Y combinator and VC backed company, raised an oversubscribed Seed Round to accelerate development and clinical studies.
 
Awards & Accelerators:
	1. Y Combinator
	2. MassChallenge
	3. Springboard Enterprises
	4. MassMedic Ignite
	5. Inc Magazine Top 100 Female Founders
	6. Women's Health Innovation Summit Award
	7. Massachusetts Life Sciences Center MassNextGen Award
	8. The Wave Summit's Emerging Women Founder in Bio Award
        9. The Eddies Award
        10. Bloomberg New Economy Catalyst


www.aoadx.com

Y Combinator

TBD Angels

The Helm

Oxford Angel Fund

Olive Tree Capital

AlleyCorp

Avestria Ventures

Rhia Ventures

Beacon Angels

Pioneer Fund

Sidecar Angels

Joyance Partners

Kyto Technology and Life Science Inc

LaunchPad Venture

VU Venture Partners

Cancer Fund

Adaptive Capital Partners

Astia

RH Capital

LabCorp Venture Fund

LongeVC

Good Growth Capital

Gore Range Capital

AOA Dx

Recuro's virtual health platform consists of a curated suite of digital solutions for healthcare.

Recuro

Binariks Inc. specializes in seamlessly integrating and optimizing digital solutions for healthcare.

Binariks Inc.

Sciensus provides patient-centric digital solutions tailored to connect patients with all stakeholders in their care.

Sciensus

AOADX is a technology company that specializes in providing innovative digital solutions. The company focuses on leveraging cutting-edge technologies to offer a suite of services that enable businesses to optimize their operations, enhance customer experiences, and drive digital transformation.

AOADX

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	May 16, 2024 5:42 AM	4c9a1a05
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	93e93842
crunchbase profile	general
li profile	general	May 16, 2024 5:42 AM	f75c721e
translate crunchbase fundingrounds	general
peers	general
news basic	general
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:AOADX

AOADX